Article
The new WHO classification for essential thrombocythemia calls for revision of available evidences.
Blood cancer journal - 25 Feb 2020
Barbui Tiziano, Thiele Jürgen, Ferrari Alberto, Vannucchi Alessandro M, Tefferi Ayalew
Abstract excerpt
In the 2016 revised classification of myeloproliferative neoplasms pre-fibrotic primary myelofibrosis (pre-PMF) was recognized as a separate entity, distinct from essential thrombocythemia (ET). Owing that the majority of cases falling in the pre-PMF category were previously diagnosed as ET, one may question about the need to re-evaluate the results of epidemiologic, clinical, and molecular studies, and the...
Topics
Join the communities discussing this publication.